Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.
July 12, 2021
Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.
- Buyers
- Hempsana Holdings Ltd.
- Targets
- Hempsana Inc.
- Sellers
- Former shareholders of Hempsana Inc.
- Industry
- Pharmaceuticals
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Curaleaf Holdings Acquires Minority Stake in Curaleaf International
July 2, 2025
Consumer Products
Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.
-
Organigram Acquires Collective Project Limited to Enter U.S. Hemp-Derived THC Beverage Market
April 1, 2025
Food & Beverage
Organigram Global Inc. acquired 100% of Collective Project Limited for approximately C$6.2 million upfront, with milestone and earnout payments linked to future beverage revenue that could bring total contingent consideration to C$24 million. The deal gives Organigram an immediate footprint in the U.S. hemp-derived THC beverage market and accelerates its entry into the cannabis beverage category in Canada by adding Collective Project’s ready-to-drink hemp/cannabis beverage portfolio and existing U.S. retail listings.
-
Curaleaf Holdings Acquires Northern Green Canada
March 19, 2024
Pharmaceuticals
Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.
-
Akanda Corp Acquires Holigen Limited
May 2, 2022
Healthcare Services
Akanda Corp entered into a definitive agreement to acquire 100% of Holigen Limited from The Flowr Corporation, adding cultivation, EU GMP manufacturing, and distribution capacity in Portugal. The deal was later reported as closed, positioning Akanda to accelerate its seed-to-patient model across EMEA and to scale toward adult-use opportunities as regulations evolve.
-
HempFusion Acquires Apothecanna
May 17, 2021
Consumer Products
HempFusion Wellness Inc. has acquired 100% of APCNA Holdings LLC (Apothecanna) for initial consideration of US$15.0 million, with up to US$10.0 million in additional milestone payments tied to revenue targets. The deal expands HempFusion's retail distribution (adding ~1,800 stores including CVS), bolsters its e-commerce presence, and is immediately accretive based on Apothecanna's ~US$3.8–4.0 million 2020 revenue.
-
Cannabinoid Biosciences Acquires CannabidiolHemp
November 25, 2019
Consumer Products
Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.